Skip to main content

Q - Chemours Co

For the period ended Jun 30, 2025. Filed Aug 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 5, 2025

CC$13.48+1.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Interim Consolidated Statements of Operations (Unaudited)

Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Net sales$1,615$1,554$2,983$2,915
Cost of goods sold1,3371,2462,4692,323
Gross profit278308514592
Selling, general, and administrative expense437154560292
Research and development expense28265553
Restructuring, asset-related, and other charges183517
Total other operating expenses483183666352
Equity in earnings of affiliates9111723
Interest expense, net(67)(66)(133)(128)
Other income (expense), net2(1)63
(Loss) income before income taxes(261)69(262)138
Provision for income taxes119912225
Net (loss) income(380)60(384)113
Less: Net income attributable to non-controlling interests1—1—
Net (loss) income attributable to Chemours$(381)$60$(385)$113
Per share data
Basic (loss) earnings per share of common stock$(2.54)$0.40$(2.56)$0.76
Diluted (loss) earnings per share of common stock(2.54)0.39(2.56)0.75
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.